In the southern US, Matt Maxwell has been working for months to recruit participants for ongoing Covid-19 vaccine trials.
But the industry behind many vaccine trials is ill-equipped to answer that call.
The work is time-intensive and, having failed to prioritize diversity until now, many organizations running clinical trials are struggling to change their practices under pressure.
But the Covid-19 vaccine trials are the first time a pharmaceutical company has asked her to recruit a demographically representative sample.
AstraZeneca did not respond to requests to provide data on diversity within its Covid-19 vaccine trials.